Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701): A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1997-09, Vol.40 (20), p.3141-3143 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3143 |
---|---|
container_issue | 20 |
container_start_page | 3141 |
container_title | Journal of medicinal chemistry |
container_volume | 40 |
creator | Meyer, Michael D Altenbach, Robert J Basha, Fatima Z Carroll, William A Drizin, Irene Elmore, Steven W Ehrlich, Paul P Lebold, Suzanne A Tietje, Karin Sippy, Kevin B Wendt, Michael D Plata, Daniel J Plagge, Fred Buckner, Steven A Brune, Michael E Hancock, Arthur A Kerwin, James F |
description | |
doi_str_mv | 10.1021/jm970364a |
format | Article |
fullrecord | <record><control><sourceid>acs_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2833128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c391881881</sourcerecordid><originalsourceid>FETCH-LOGICAL-a978-445149f7b736dfe714aec45f4808cb3c4449e0cfd749399bb6e521aeb41ee00c3</originalsourceid><addsrcrecordid>eNo9Uk2O0zAYDQgkysCCG3gBUivF4L80zWxQp2IoYoAyLQKpqiLH-dK4JHbkBNTMarbcgGtwEQ4xJ8GdotnY-vyen_3e9wXBM0peUsLoq12dxISPhbwfDGjECBYTIh4EA0IYw2zM-KPgcdvuCCGcMj6493rZm66EVrdImhwtSulqqWxlt1rJCs18LVUHTl_JTluDbIE4XjM8HHJ5GSbZ5Qgr3eIx_gBdafc9RizkIZehCCMP4xL2suxzZzGdY5SBuVrDRrdWm9xWmOG-GvmLfbVpeqdzu-Y3179D4ZdTL7DpSg3GH4YM57eMWufawOERMaTzkM9HOPffAjScYsppTOjo9Ob6F5qiL862UIHq9E9Af__QKZrmzospaDrr0NR0cmuNbjtU-NJHgJZ97aHa-1Ro5UB2NZjuYPgMjN4atPCK3S067xtwTSVbLZ8EDwtZtfD0_34SrM7frGZzfPHp7bvZ9ALLJJ5gISIqkiLOYj7OC4ipkKBEVPjmTFTGlRAiAaKKPBYJT5IsG0PEqIRMUABCFD8Jnh9lG9n6vhROGh972vhEpOtTNuG-nRNPw0ea9wX7O1i67-k45nGUrhbL9PO36Ozr5P15-tHzXxz5UrXpzv5wxntIKUkPs5TezRL_B1WTvXE</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701): A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</title><source>ACS Publications</source><creator>Meyer, Michael D ; Altenbach, Robert J ; Basha, Fatima Z ; Carroll, William A ; Drizin, Irene ; Elmore, Steven W ; Ehrlich, Paul P ; Lebold, Suzanne A ; Tietje, Karin ; Sippy, Kevin B ; Wendt, Michael D ; Plata, Daniel J ; Plagge, Fred ; Buckner, Steven A ; Brune, Michael E ; Hancock, Arthur A ; Kerwin, James F</creator><creatorcontrib>Meyer, Michael D ; Altenbach, Robert J ; Basha, Fatima Z ; Carroll, William A ; Drizin, Irene ; Elmore, Steven W ; Ehrlich, Paul P ; Lebold, Suzanne A ; Tietje, Karin ; Sippy, Kevin B ; Wendt, Michael D ; Plata, Daniel J ; Plagge, Fred ; Buckner, Steven A ; Brune, Michael E ; Hancock, Arthur A ; Kerwin, James F</creatorcontrib><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm970364a</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Medical sciences ; Pharmacology. Drug treatments ; Urinary system</subject><ispartof>Journal of medicinal chemistry, 1997-09, Vol.40 (20), p.3141-3143</ispartof><rights>Copyright © 1997 American Chemical Society</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm970364a$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm970364a$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2833128$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Meyer, Michael D</creatorcontrib><creatorcontrib>Altenbach, Robert J</creatorcontrib><creatorcontrib>Basha, Fatima Z</creatorcontrib><creatorcontrib>Carroll, William A</creatorcontrib><creatorcontrib>Drizin, Irene</creatorcontrib><creatorcontrib>Elmore, Steven W</creatorcontrib><creatorcontrib>Ehrlich, Paul P</creatorcontrib><creatorcontrib>Lebold, Suzanne A</creatorcontrib><creatorcontrib>Tietje, Karin</creatorcontrib><creatorcontrib>Sippy, Kevin B</creatorcontrib><creatorcontrib>Wendt, Michael D</creatorcontrib><creatorcontrib>Plata, Daniel J</creatorcontrib><creatorcontrib>Plagge, Fred</creatorcontrib><creatorcontrib>Buckner, Steven A</creatorcontrib><creatorcontrib>Brune, Michael E</creatorcontrib><creatorcontrib>Hancock, Arthur A</creatorcontrib><creatorcontrib>Kerwin, James F</creatorcontrib><title>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701): A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Urinary system</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9Uk2O0zAYDQgkysCCG3gBUivF4L80zWxQp2IoYoAyLQKpqiLH-dK4JHbkBNTMarbcgGtwEQ4xJ8GdotnY-vyen_3e9wXBM0peUsLoq12dxISPhbwfDGjECBYTIh4EA0IYw2zM-KPgcdvuCCGcMj6493rZm66EVrdImhwtSulqqWxlt1rJCs18LVUHTl_JTluDbIE4XjM8HHJ5GSbZ5Qgr3eIx_gBdafc9RizkIZehCCMP4xL2suxzZzGdY5SBuVrDRrdWm9xWmOG-GvmLfbVpeqdzu-Y3179D4ZdTL7DpSg3GH4YM57eMWufawOERMaTzkM9HOPffAjScYsppTOjo9Ob6F5qiL862UIHq9E9Af__QKZrmzospaDrr0NR0cmuNbjtU-NJHgJZ97aHa-1Ro5UB2NZjuYPgMjN4atPCK3S067xtwTSVbLZ8EDwtZtfD0_34SrM7frGZzfPHp7bvZ9ALLJJ5gISIqkiLOYj7OC4ipkKBEVPjmTFTGlRAiAaKKPBYJT5IsG0PEqIRMUABCFD8Jnh9lG9n6vhROGh972vhEpOtTNuG-nRNPw0ea9wX7O1i67-k45nGUrhbL9PO36Ozr5P15-tHzXxz5UrXpzv5wxntIKUkPs5TezRL_B1WTvXE</recordid><startdate>19970926</startdate><enddate>19970926</enddate><creator>Meyer, Michael D</creator><creator>Altenbach, Robert J</creator><creator>Basha, Fatima Z</creator><creator>Carroll, William A</creator><creator>Drizin, Irene</creator><creator>Elmore, Steven W</creator><creator>Ehrlich, Paul P</creator><creator>Lebold, Suzanne A</creator><creator>Tietje, Karin</creator><creator>Sippy, Kevin B</creator><creator>Wendt, Michael D</creator><creator>Plata, Daniel J</creator><creator>Plagge, Fred</creator><creator>Buckner, Steven A</creator><creator>Brune, Michael E</creator><creator>Hancock, Arthur A</creator><creator>Kerwin, James F</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope></search><sort><creationdate>19970926</creationdate><title>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701): A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</title><author>Meyer, Michael D ; Altenbach, Robert J ; Basha, Fatima Z ; Carroll, William A ; Drizin, Irene ; Elmore, Steven W ; Ehrlich, Paul P ; Lebold, Suzanne A ; Tietje, Karin ; Sippy, Kevin B ; Wendt, Michael D ; Plata, Daniel J ; Plagge, Fred ; Buckner, Steven A ; Brune, Michael E ; Hancock, Arthur A ; Kerwin, James F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a978-445149f7b736dfe714aec45f4808cb3c4449e0cfd749399bb6e521aeb41ee00c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meyer, Michael D</creatorcontrib><creatorcontrib>Altenbach, Robert J</creatorcontrib><creatorcontrib>Basha, Fatima Z</creatorcontrib><creatorcontrib>Carroll, William A</creatorcontrib><creatorcontrib>Drizin, Irene</creatorcontrib><creatorcontrib>Elmore, Steven W</creatorcontrib><creatorcontrib>Ehrlich, Paul P</creatorcontrib><creatorcontrib>Lebold, Suzanne A</creatorcontrib><creatorcontrib>Tietje, Karin</creatorcontrib><creatorcontrib>Sippy, Kevin B</creatorcontrib><creatorcontrib>Wendt, Michael D</creatorcontrib><creatorcontrib>Plata, Daniel J</creatorcontrib><creatorcontrib>Plagge, Fred</creatorcontrib><creatorcontrib>Buckner, Steven A</creatorcontrib><creatorcontrib>Brune, Michael E</creatorcontrib><creatorcontrib>Hancock, Arthur A</creatorcontrib><creatorcontrib>Kerwin, James F</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meyer, Michael D</au><au>Altenbach, Robert J</au><au>Basha, Fatima Z</au><au>Carroll, William A</au><au>Drizin, Irene</au><au>Elmore, Steven W</au><au>Ehrlich, Paul P</au><au>Lebold, Suzanne A</au><au>Tietje, Karin</au><au>Sippy, Kevin B</au><au>Wendt, Michael D</au><au>Plata, Daniel J</au><au>Plagge, Fred</au><au>Buckner, Steven A</au><au>Brune, Michael E</au><au>Hancock, Arthur A</au><au>Kerwin, James F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701): A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1997-09-26</date><risdate>1997</risdate><volume>40</volume><issue>20</issue><spage>3141</spage><epage>3143</epage><pages>3141-3143</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><cop>Washington, DC</cop><pub>American Chemical Society</pub><doi>10.1021/jm970364a</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1997-09, Vol.40 (20), p.3141-3143 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_pascalfrancis_primary_2833128 |
source | ACS Publications |
subjects | Biological and medical sciences Medical sciences Pharmacology. Drug treatments Urinary system |
title | Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701): A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T06%3A39%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Pharmacological%20Characterization%20of%203-%5B2-((3aR,9bR)-cis-6-Methoxy-%202,3,3a,4,5,9b-hexahydro-1H-%20benz%5Be%5Disoindol-2-yl)ethyl%5Dpyrido%5B3%E2%80%98,4%E2%80%98:4,5%5Dthieno%5B3,2-d%5Dpyrimidine-%202,4(1H,3H)-dione%20(A-131701):%E2%80%89%20A%20Uroselective%20%CE%B11A%20Adrenoceptor%20Antagonist%20for%20the%20Symptomatic%20Treatment%20of%20Benign%20Prostatic%20Hyperplasia&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Meyer,%20Michael%20D&rft.date=1997-09-26&rft.volume=40&rft.issue=20&rft.spage=3141&rft.epage=3143&rft.pages=3141-3143&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm970364a&rft_dat=%3Cacs_pasca%3Ec391881881%3C/acs_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |